Evolus, Inc. (EOLS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 12.61 |
| Open | 12.73 |
| Bid | 12.92 x 100 |
| Ask | 12.96 x 100 |
| Day's range | 12.67 - 13.00 |
| 52-week range | 7.07 - 15.43 |
| Volume | |
| Avg. volume | 601,303 |
| Market cap | 809.554M |
| Beta (5Y monthly) | 1.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Evolus (EOLS) Releases Favorable Dermal Fillers Study Data
The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.
- GuruFocus.com
Director David Gill Sells 10,361 Shares of Evolus Inc (EOLS)
On May 14, 2024, David Gill, Director at Evolus Inc (NASDAQ:EOLS), executed a sale of 10,361 shares of the company.
- GuruFocus.com
Director Vikram Malik Sells 28,000 Shares of Evolus Inc (EOLS)
On May 13, 2024, Vikram Malik, Director of Evolus Inc (NASDAQ:EOLS), executed a sale of 28,000 shares of the company.
© 2024 Yahoo. All rights reserved.